BR100 Decreased By (-0.7%)
BR30 Decreased By (-0.59%)
KSE100 Decreased By (-0.64%)
KSE30 Decreased By (-0.82%)
BECO 5.62 Decreased By ▼ -0.02 (-0.35%)
BML 60.60 Increased By ▲ 1.88 (3.2%)
BOP 37.42 Increased By ▲ 0.29 (0.78%)
CNERGY 8.51 Increased By ▲ 0.01 (0.12%)
DCL 11.72 Decreased By ▼ -0.18 (-1.51%)
FCCL 57.91 Decreased By ▼ -0.72 (-1.23%)
FCSC 5.08 Increased By ▲ 0.03 (0.59%)
FFL 17.92 Decreased By ▼ -0.18 (-0.99%)
FNEL 1.25 Increased By ▲ 0.01 (0.81%)
HUMNL 11.20 Decreased By ▼ -0.05 (-0.44%)
KEL 8.15 Decreased By ▼ -0.02 (-0.24%)
KOSM 6.45 Decreased By ▼ -0.02 (-0.31%)
MLCF 107.10 Decreased By ▼ -2.41 (-2.2%)
NBP 218.57 Increased By ▲ 1.09 (0.5%)
PACE 11.20 Increased By ▲ 0.05 (0.45%)
PAEL 47.23 Increased By ▲ 0.51 (1.09%)
PIAHCLA 30.65 Increased By ▲ 0.05 (0.16%)
PIBTL 18.71 Decreased By ▼ -0.15 (-0.8%)
PPL 247.25 Decreased By ▼ -5.41 (-2.14%)
PRL 37.20 Increased By ▲ 0.75 (2.06%)
PTC 71.44 Decreased By ▼ -2.52 (-3.41%)
SEARL 99.29 Increased By ▲ 0.30 (0.3%)
SSGC 32.01 Decreased By ▼ -0.34 (-1.05%)
TELE 9.20 Increased By ▲ 0.11 (1.21%)
THCCL 74.25 Increased By ▲ 5.12 (7.41%)
TPLP 13.37 Increased By ▲ 0.83 (6.62%)
TREET 25.85 Increased By ▲ 0.06 (0.23%)
TRG 67.57 Increased By ▲ 0.27 (0.4%)
WAVES 11.52 Increased By ▲ 0.15 (1.32%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
By

WASHINGTON: The United States on on Tuesday signed a $1.95 billion agreement with US pharma giant Pfizer and Germany's BioNTech for 100 million doses of their experimental Covid-19 vaccine, part of an aggressive push to start immunizing Americans early next year.

It is the biggest deal to date under Operation Warp Speed, intended to accelerate the development, manufacturing, and distribution of coronavirus vaccines, therapeutics, and diagnostics.

Pfizer and BioNTech, which are developing the drug together, said in statements that the American people would receive the future vaccine "for free" in line with the Trump administration's pledge.

Under the agreement, the US government has placed an initial order for 100 million doses to be delivered if regulatory approval is granted.

Comments

Comments are closed for this article.